We observed significant reduction in tumor growth (Figure 5B) and tumor wet weight (Figure 5C) when HPAFII tumor bearing mice were treated with TGF-β antibody as compared to those in the control IgG group. This evidence concerns the gene TGFB1 and neoplasm.